Robinson Pharma Expands Costa Mesa, California, Operations
09/17/2019
According to company officials, this new addition brings Robinson Pharma to now six buildings and totaling over 650,000 square feet. The new state-of-the-art eco-friendly facility will serve as RPI’s newest expansion to accommodate its continuing business growth.
The building spans 100,276 square feet and sits on more than five acres of land. RPI has committed to invest $20M in this facility to better serve its customers with the latest advances in nutraceutical contract manufacturing and quality assurance.
With these new investments, RPI said it will keep pace with the growing demand for wellness products and continue in its vision to provide the best in service in the supplement industry.
Robinson Pharma, Inc., is a Southern California-based full-service contract manufacturer of dietary supplements with over 650,000 square feet of production capabilities of capsules, softgels, tablets, powders, and liquids. Robinson Pharma, Inc. possesses multiple third-party certifications of current Good Manufacturing Practice (cGMP) and Safe Quality Food (SQF) compliance from well-reputed organizations, such as Eurofins, NPA, NSF, and UL for supplement manufacturing in the United States.
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024